LORANGER STEVEN R

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$1.14M
Insider Sells Quantity
27
Insider Sells Sum
$100.88M

Insider Activity of LORANGER STEVEN R

The largest purchase of all time was on 2016-05-24 and amounted to 5000 shares of Edwards Lifesciences Corporation for $505,344.

The largest sale of all time was on 2012-02-09 and amounted to 398240 shares of Xylem Inc. for $10.63M.

Biography of LORANGER STEVEN R

No biography is available at this moment.

2020-09-11SaleXylem Inc.
XYL
director
36,776
0.0203%
$83.95$3.09M+23.78%
2020-02-12SaleXylem Inc.
XYL
director
60,000
0.0331%
$88.61$5.32M-7.78%
2019-03-15SaleXylem Inc.
XYL
director
20,000
0.0112%
$76.99$1.54M+3.48%
2017-12-20SaleXylem Inc.
XYL
director
24,240
0.0135%
$68.14$1.65M+6.7%
2017-12-19SaleXylem Inc.
XYL
director
10,038
0.0056%
$68.00$682,628+6.64%
2017-12-18SaleXylem Inc.
XYL
director
95,424
0.0532%
$68.10$6.5M+6.58%
2017-12-13SaleXylem Inc.
XYL
director
400
0.0002%
$68.02$27,208+7.23%
2017-12-11SaleXylem Inc.
XYL
director
392
0.0002%
$68.23$26,746+7.56%
2017-11-06SaleXylem Inc.
XYL
director
75,400
0.0417%
$66.25$5M+8.6%
2017-06-29SaleXylem Inc.
XYL
director
19,866
0.0111%
$55.05$1.09M+24.92%
2017-06-28SaleXylem Inc.
XYL
director
112,398
0.0626%
$55.00$6.18M+24.76%
2016-08-11SaleXylem Inc.
XYL
director
57,464
0.0318%
$48.13$2.77M+5.25%
2016-08-10SaleXylem Inc.
XYL
director
10,310
0.0058%
$48.00$494,880+6.66%
2016-07-28SaleXylem Inc.
XYL
director
64,492
0.0361%
$48.01$3.1M+6.27%
2016-06-01SaleXylem Inc.
XYL
director
100,000
0.0555%
$44.52$4.45M+11.18%
2016-05-27SaleXylem Inc.
XYL
director
100,000
0.056%
$44.67$4.47M+11.76%
2016-05-24PurchaseEdwards Lifesciences Corporation
EW
director
5,000
0.0023%
$101.07$505,344-3.17%
2015-11-05SaleXylem Inc.
XYL
director
200,000
0.1118%
$36.73$7.35M+17.01%
2015-11-04SaleXylem Inc.
XYL
director
131,380
0.0735%
$36.62$4.81M+17.44%
2014-11-12SaleXylem Inc.
XYL
director
200,000
0.1097%
$37.51$7.5M-4.56%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.